메뉴 건너뛰기




Volumn 61, Issue 3, 2012, Pages 353-362

Metronomic cyclophosphamide treatment in metastasized breast cancer patients: Immunological effects and clinical outcome

Author keywords

Breast cancer; Immunomodulation; Low dose cyclophosphamide; Regulatory T cells; Tumor specific T cells

Indexed keywords

CYCLOPHOSPHAMIDE; ALKYLATING AGENT; GAMMA INTERFERON;

EID: 84860815596     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-011-1106-3     Document Type: Article
Times cited : (201)

References (37)
  • 1
    • 16844365788 scopus 로고    scopus 로고
    • + regulatory T cells in immunological tolerance to self and non-self
    • + regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6:345-352
    • (2005) Nat Immunol , vol.6 , pp. 345-352
    • Sakaguchi, S.1
  • 3
    • 33645286546 scopus 로고    scopus 로고
    • Regulatory T cells, tumour immunity and immunotherapy
    • Zou W (2006) Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 6:295-307
    • (2006) Nat Rev Immunol , vol.6 , pp. 295-307
    • Zou, W.1
  • 5
    • 21244484329 scopus 로고    scopus 로고
    • Maintenance of long-term tumour-specific T-cell memory by residual dormant tumour cells
    • DOI 10.1111/j.1365-2567.2005.02163.x
    • Mahnke YD, Schwendemann J, Beckhove P, Schirrmacher V (2005) Maintenance of long-term tumour-specific T-cell memory by residual dormant tumour cells. Immunology 115:325-336 (Pubitemid 40896031)
    • (2005) Immunology , vol.115 , Issue.3 , pp. 325-336
    • Mahnke, Y.D.1    Schwendemann, J.2    Beckhove, P.3    Schirrmacher, V.4
  • 7
    • 77952391928 scopus 로고    scopus 로고
    • Tumor regulatory T cells potently abrogate antitumour immunity
    • Liu Z, Kim JH, Falo LD Jr, You Z (2009) Tumor regulatory T cells potently abrogate antitumour immunity. J Immunol 182:6160-6167
    • (2009) J Immunol , vol.182 , pp. 6160-6167
    • Liu, Z.1    Kim, J.H.2    Falo Jr., L.D.3    You, Z.4
  • 18
    • 0015762456 scopus 로고
    • A human cell line from a pleural effusion derived from a breast carcinoma
    • Soule HD, Vazguez J, Long A, Albert S, Brennan M (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51:1409-1416
    • (1973) J Natl Cancer Inst , vol.51 , pp. 1409-1416
    • Soule, H.D.1    Vazguez, J.2    Long, A.3    Albert, S.4    Brennan, M.5
  • 19
  • 20
    • 11944262611 scopus 로고    scopus 로고
    • A CD80-transfected human breast cancer cell variant induces HER-2/neu-specific T cells in HLA-A*02-matched situations in vitro as well as in vivo
    • DOI 10.1007/s00262-004-0583-z
    • Gückel B, Stumm S, Rentzsch C, Marmé A, Mannhardt G, Wallwiener D (2005) A CD80-transfected human breast cancer cell variant induces HER-2/neu-specific T cells in HLA-A*02-matched situations in vitro as well as in vivo. Cancer Immunol Immunother 54:129-140 (Pubitemid 40100835)
    • (2005) Cancer Immunology, Immunotherapy , vol.54 , Issue.2 , pp. 129-140
    • Guckel, B.1    Stumm, S.2    Rentzsch, C.3    Marme, A.4    Mannhardt, G.5    Wallwiener, D.6
  • 23
    • 68949180445 scopus 로고    scopus 로고
    • Metronomic chemotherapy: Changing the paradigm that more is better
    • Scharovsky OG, Mainetti LE, Rozados VR (2009) Metronomic chemotherapy: changing the paradigm that more is better. Curr Oncol 16:7-15
    • (2009) Curr Oncol , vol.16 , pp. 7-15
    • Scharovsky, O.G.1    Mainetti, L.E.2    Rozados, V.R.3
  • 24
    • 33644789357 scopus 로고    scopus 로고
    • Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients
    • DOI 10.1200/JCO.2005.12.147
    • Correale P, Cusi MG, Tsang KY, Del Vecchio MT, Marsili S, Placa ML, Intrivici L, Aquino A, Micheli L, Nencini C, Ferrari F, Giorgi G, Bonmassar E, Francini G (2005) Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumour activity in metastatic colon cancer patients. J Clin Oncol 23:8950-8958 (Pubitemid 46211480)
    • (2005) Journal of Clinical Oncology , vol.23 , Issue.35 , pp. 8950-8958
    • Correale, P.1    Cusi, M.G.2    Tsang, K.Y.3    Del, V.M.T.4    Marsili, S.5    La, P.M.6    Intrivici, C.7    Aquino, A.8    Micheli, L.9    Nencini, C.10    Ferrari, F.11    Giorgi, G.12    Bonmassar, E.13    Francini, G.14
  • 26
    • 33748052024 scopus 로고    scopus 로고
    • The shaping of a polyvalent and highly individual T-cell repertoire in the bone marrow of breast cancer patients
    • DOI 10.1158/0008-5472.CAN-05-4201
    • Sommerfeldt N, Schütz F, Sohn C, Förster J, Schirrmacher V, Beckhove P (2006) The shaping of a polyvalent and highly individual T-cell repertoire in the bone marrow of breast cancer patients. Cancer Res 66:8258-8265 (Pubitemid 44299195)
    • (2006) Cancer Research , vol.66 , Issue.16 , pp. 8258-8265
    • Sommerfeldt, N.1    Schutz, F.2    Sohn, C.3    Forster, J.4    Schirrmacher, V.5    Beckhove, P.6
  • 27
    • 2242419092 scopus 로고    scopus 로고
    • Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense
    • DOI 10.1126/science.1076064
    • Messaoudi I, Guevara Patin JA, Dyall R, LeMaoult J, Nikolich-Zugich J (2002) Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. Science 298:1797-1800 (Pubitemid 35404125)
    • (2002) Science , vol.298 , Issue.5599 , pp. 1797-1800
    • Messaoudi, I.1    Guevara, P.J.A.2    Dyall, R.3    LeMaoult, J.4    Nikolich-Zugich, J.5
  • 29
    • 0036897097 scopus 로고    scopus 로고
    • Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs
    • Bocci G, Nicolaou KC, Kerbel RS (2002) Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs. Cancer Res 62:6938-6943 (Pubitemid 35424084)
    • (2002) Cancer Research , vol.62 , Issue.23 , pp. 6938-6943
    • Bocci, G.1    Nicolaou, K.C.2    Kerbel, R.S.3
  • 30
    • 27644436870 scopus 로고    scopus 로고
    • Optimal biologic dose of metronomic chemotherapy regimens is associated with maximum antiangiogenic activity
    • DOI 10.1182/blood-2005-04-1422
    • Shaked Y, Emmenegger U, Man S, Cervi D, Bertolini F, Ben-David Y, Kerbel RS (2005) Optimal biologic dose of metronomic chemotherapy regimens is associated with maximum antiangiogenic activity. Blood 106:3058-3061 (Pubitemid 41565900)
    • (2005) Blood , vol.106 , Issue.9 , pp. 3058-3061
    • Shaked, Y.1    Emmenegger, U.2    Man, S.3    Cervi, D.4    Bertolini, F.5    Ben-David, Y.6    Kerbel, R.S.7
  • 31
    • 77953730756 scopus 로고    scopus 로고
    • + regulatory T cells by low-dose cyclophosphamide is explained by reduced intracellular ATP levels
    • + regulatory T cells by low-dose cyclophosphamide is explained by reduced intracellular ATP levels. Cancer Res 70:4850-4858
    • (2010) Cancer Res , vol.70 , pp. 4850-4858
    • Zhao, J.1    Cao, Y.2    Lei, Z.3    Yang, Z.4    Zhang, B.5    Huang, B.6
  • 33
    • 70350108862 scopus 로고    scopus 로고
    • Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination
    • Radojcic V, Bezak KB, Skarica M, Pletneva MA, Yoshimura K, Schulick RD, Luznik L (2010) Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination. Cancer Immunol Immunother 59:137-148
    • (2010) Cancer Immunol Immunother , vol.59 , pp. 137-148
    • Radojcic, V.1    Bezak, K.B.2    Skarica, M.3    Pletneva, M.A.4    Yoshimura, K.5    Schulick, R.D.6    Luznik, L.7
  • 34
    • 0036669298 scopus 로고    scopus 로고
    • CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice: Implications for the nonredundant function of IL-2
    • DOI 10.1016/S1074-7613(02)00367-9
    • Malek TR, Yu A, Vincek V, Scibelli P, Kong L (2002) CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity 17:167-178 (Pubitemid 35245959)
    • (2002) Immunity , vol.17 , Issue.2 , pp. 167-178
    • Malek, T.R.1    Yu, A.2    Vincek, V.3    Scibelli, P.4    Kong, L.5
  • 36
    • 0034716925 scopus 로고    scopus 로고
    • Regulatory T cells: Key controllers of immunologic self-tolerance
    • Sakaguchi S (2000) Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101:455-458
    • (2000) Cell , vol.101 , pp. 455-458
    • Sakaguchi, S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.